scholarly journals Comparative efficacy and safety of axitinib versus sorafenib in metastatic renal cell carcinoma: a systematic review and meta-analysis

2016 ◽  
pp. 3423 ◽  
Author(s):  
Hai Wang ◽  
Guizhong Li ◽  
Guanglin Huang ◽  
Jianwei Wang ◽  
Libo Man
Sign in / Sign up

Export Citation Format

Share Document